Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719986 | SCV000235972 | likely benign | not provided | 2020-01-08 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27037756, 20864495, 31402444) |
Invitae | RCV000645215 | SCV000766957 | benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001124648 | SCV001283631 | uncertain significance | Naxos disease | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001124649 | SCV001283632 | uncertain significance | Arrhythmogenic right ventricular dysplasia 12 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ambry Genetics | RCV002408705 | SCV002713993 | likely benign | Cardiovascular phenotype | 2021-02-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003149960 | SCV003838225 | benign | Cardiomyopathy | 2021-11-25 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000157251 | SCV000206981 | uncertain significance | Ventricular fibrillation, paroxysmal familial, type 1 | 2014-09-24 | no assertion criteria provided | clinical testing |